Clinical News

Launch of IAS Report 'Dead on Arrival? Evaluating the Public Health Responsibility Deal for Alcohol'

Monday, 09 November 2015 10:42

Today the Institute of Alcohol Studies (IAS) has published a report condemning the Public Health Responsibility Deal for Alcohol, suggesting it has "worsened the health of the nation". Titled Dead on Arrival? Evaluating the Public Health Responsibility Deal for Alcohol, the report's main findings include:

  • The Responsibility Deal is not endorsed by academics or the public health community
  • It has pursued initiatives known to have limited efficacy in reducing alcohol-related harm
  • The evidence on the effectiveness of the Responsibility Deal is limited and unreliable, due to ambiguous goals and poor reporting practices
  • Where evaluation has been possible, implementation has often failed to live up to the letter and/or spirit of the pledges
  • The Responsibility Deal appears to have obstructed more meaningful initiatives with a stronger evidence base behind them

Hepatitis C ODNs service specification published

Wednesday, 21 October 2015 13:44

NHS England has published the service specification for Operational Delivery Networks (ODNs) for hepatitis C care in adults. The full document is available below. Many BSG members will have been involved in the set up processes to date at a local level but this provides NHS England's final specification document.

The BSG, through Steve Ryder and others, continue to engage with NHS England on the detailed operation of ODNs (including data requirements) and the opportunities for clinical peer review amongst ODNs.

Royal College of Nursing launches framework to improve care for liver disease patients

Wednesday, 07 October 2015 11:52

The Royal College of Nursing (RCN) has launched a revised competence framework to help improve nursing care for people with liver disease. The framework, published on 18th September and launched at the British Liver Nurses' Forum 17th Annual Conference, aims to promote education and training in this area.

The framework is authored by RCN members Lynda Greenslade, Clinical Nurse Specialist in Hepatology at the Royal Free London NHS Foundation Trust, and Michelle Clayton, Lecturer in Liver Care at the University of Leeds. It describes the professional standards expected of practitioners when caring for adults and young people across England with liver disease. The framework is applicable to nursing staff in primary and secondary care settings, and is also suitable for use by healthcare practitioners such as GPs and liver dieticians.

The framework also highlights how liver disease was formerly considered to be a rare disease, but now is the fifth most common cause of death in the UK, namely as a result of alcohol, viral hepatitis and obesity leading to non-alcoholic fatty liver disease (NAFLD).

The RCN press release on the framework's publication can be found here, and the full framework can be found here.

Fourth report of the biological therapy element of the UK IBD audit

Thursday, 24 September 2015 14:32

Latest UK IBD audit report shows further improvement for patients following treatment with biological therapies

The UK inflammatory bowel disease (IBD) clinical audit report reveals today that the majority of patients (80% adult and 77% paediatric) with Crohn's disease saw an improvement following biological therapies

This is the fourth report of the biological therapy element of the UK IBD audit. The purpose of this audit is to measure the efficacy, safety and appropriate use of the biological therapies infliximab and adalimumab, also known as anti-TNFα drugs, in patients with IBD in the UK. The audit also aims to capture patients’ views on their quality of life at intervals during their treatment.

The data presented in the reports demonstrate that biological therapies for IBD are effective and relatively safe treatments. Patterns of use are changing, with earlier use in patients with less severe disease. It is likely that this reflects more appropriate prescribing as physicians become more familiar with these drugs.

National and executive summary versions of both adult and paediatric reports are available on the Royal College of Physicians' website:

Page 5 of 8